Clinical Trial Update: Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a circulating tumor DNA-guided neoadjuvant treatment strategy for locally advanced rectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Locally Advanced Rectal Carcinoma, Circulating Tumor DNA | Phase 2 | Status: RECRUITING